For clinical trials, commercialization or reformulations, KORU assists with planning and executing large-volume subcutaneous drug delivery, drawing on more than three decades of experience supporting the home healthcare infusion industry with more than 1.5 million annual infusions. Its FDA-cleared, complete portable infusion systems include a choice of two infusion pumps plus a variety of flow-rate tubing and subcutaneous needle set options already cleared for use with immunoglobulin and other therapies.

No comments available.
Leave your rating & comment